These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 31311713)
1. Acute hepatic porphyrias: Current diagnosis & management. Anderson KE Mol Genet Metab; 2019 Nov; 128(3):219-227. PubMed ID: 31311713 [TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. Wang B; Bonkovsky HL; Lim JK; Balwani M Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627 [TBL] [Abstract][Full Text] [Related]
3. Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples. Moghe A; Dickey A; Erwin A; Leaf RK; O'Brien A; Quigley JG; Thapar M; Anderson KE Mol Genet Metab; 2023 Nov; 140(3):107670. PubMed ID: 37542766 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Bonkovsky HL; Dixon N; Rudnick S Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinate dehydratase porphyria: Update on hepatic 5-aminolevulinic acid synthase induction and long-term response to hemin. Lahiji AP; Anderson KE; Chan A; Simon A; Desnick RJ; Ramanujam VMS Mol Genet Metab; 2020 Dec; 131(4):418-423. PubMed ID: 33199206 [TBL] [Abstract][Full Text] [Related]
6. Hepatic porphyria: A narrative review. Arora S; Young S; Kodali S; Singal AK Indian J Gastroenterol; 2016 Nov; 35(6):405-418. PubMed ID: 27796941 [TBL] [Abstract][Full Text] [Related]
7. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives. Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955 [TBL] [Abstract][Full Text] [Related]
8. Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments. Manceau H; Gouya L; Puy H Curr Opin Hematol; 2017 May; 24(3):198-207. PubMed ID: 28118224 [TBL] [Abstract][Full Text] [Related]
9. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study. Wang B; Ventura P; Takase KI; Thapar M; Cassiman D; Kubisch I; Liu S; Sweetser MT; Balwani M Orphanet J Rare Dis; 2022 Aug; 17(1):327. PubMed ID: 36028858 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of the hepatic porphyrias. Lecha M; Herrero C; Ozalla D Dermatol Ther; 2003; 16(1):65-72. PubMed ID: 12919129 [TBL] [Abstract][Full Text] [Related]
13. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians. Anderson KE; Lobo R; Salazar D; Schloetter M; Spitzer G; White AL; Young RM; Bonkovsky HL; Frank EL; Mora J; Tortorelli S Am J Med Sci; 2021 Aug; 362(2):113-121. PubMed ID: 33865828 [TBL] [Abstract][Full Text] [Related]
14. Modern diagnosis and management of the porphyrias. Sassa S Br J Haematol; 2006 Nov; 135(3):281-92. PubMed ID: 16956347 [TBL] [Abstract][Full Text] [Related]
15. Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing. Anderson KE; Desnick RJ; Stewart MF; Ventura P; Bonkovsky HL Am J Med Sci; 2022 Jan; 363(1):1-10. PubMed ID: 34606756 [TBL] [Abstract][Full Text] [Related]